Fabtech Technologies Reports Consolidated Order Book Exceeding ₹900 Crore Amid Global Growth Initiatives

Fabtech Technologies Reports Consolidated Order Book Exceeding ₹900 Crore Amid Global Growth Initiatives​

Fabtech Technologies Limited announced business updates for the year ended March 31, 2026, highlighting the company's sustained performance and strategic expansion across multiple high-growth sectors and geographies. As of March 31, 2026, the company reported a consolidated order book surpassing ₹900 crore.

The company navigated an environment marked by heightened global volatility, including disruptions in logistics, freight movements, and cost escalations for key inputs, during the year. Fabtech Technologies stated that its execution model proved resilient, allowing the company to manage these transient challenges with minimal impact on overall performance.

Several strategically significant, high-impact projects were secured and advanced during the period, bolstering the company's market positioning. These developments include:

• Entry and expansion within the animal health segment.
• Execution of vaccine and advanced pharmaceutical projects in the Kingdom of Saudi Arabia.
• Tackling large-scale pharmaceutical and infrastructure projects across Africa.

These advancements reinforce the company’s standing in sectors experiencing high growth and strengthens its global execution platform.

The company remains optimistic regarding its growth trajectory, citing the robust order book, expanding market presence, and continued focus on complex, value-accretive projects. Detailed financial results are scheduled for announcement at a later date.

Source:​